Genes for Induction of T Cell Responses
诱导 T 细胞反应的基因
基本信息
- 批准号:7756631
- 负责人:
- 金额:$ 45.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAcuteAmino Acid SequenceAntibodiesAntigensBindingCellsChronicConsensusDNADevelopmentEpitopesGaggingGenerationsGenesGeneticGenetic VariationGrantHIV InfectionsHIV-1HIV-1 vaccineImmune responseLeadMacaca mulattaMouse StrainsMusPrincipal InvestigatorScreening procedureT-LymphocyteTestingUpdateVaccine DesignVaccinesVaccinia virusVirusVirus Diseasesclinical efficacycomparativedesignenv Genesfusion genegene inductionimmunogenicityneutralizing antibodynonhuman primatenovelprogramsresponse
项目摘要
The extraordinary genetic diversity among globally circulating HIV-1 strains poses a formidable
challenge for HIV-1 vaccine design. Therefore, AIDS vaccines that can induce broadly reactive and potent T cell immune responses are urgently needed. In our recent studies, we have generated two synthetic group M consensus env genes (CON6 and CON-S) of all HIV-1 subtypes. The genetic distance between the group M consensus env sequences and any subtype env sequences is only half of those among subtype env sequences to each other (15% vs. 30%). Our preliminary results have shown that both CON6 and CON-S were biologically functional, preserved key antibody binding epitopes and, most importantly, induced T cell responses in three strains of mice that were more cross-reactive than single subtype env immunogens, and were similar in breadth to a subtype A, B and C env polyvalent immunogen. Project 3 will test T cell immune responses induced by a spectrum of centralized HIV-1 genes in mice using a DMA prime-recombinant vaccinia virus boost screening strategy, and comprehensively evaluate the centralized gene approach for development of HIV-1 immunogens that induce potent cross-reactive anti-HIV-1 T cell responses. We will: 1) identify optimal consensus env immunogens that induce broad cross-reactive T cell responses, 2) determine which centralized immunogen designs can induce the broadest T cell immune responses
in mice, 3) determine if the group M consensus gag-pol-nef fusion gene immunogens can induce
broader T cell immune responses than contemporary subtype (A, B and C) gag-pol-nef fusion gene immunogens, and 4) study the subtype consensus env immunogens from acute infection viruses and other newer generations of centralized genes from Project 1 to identify optimal immunogens for inducing broadly reactive T cell responses. The immunogens that induce optimal T cell responses will be evaluated in non-human primates in Project 4.
在全球传播的HIV-1毒株中,非同寻常的遗传多样性构成了一个可怕的威胁
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FENG GAO其他文献
FENG GAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FENG GAO', 18)}}的其他基金
Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCT
中和抗体在 HIV-1 感染和接种疫苗的母亲中在 MTCT 中的作用
- 批准号:
9294963 - 财政年份:2016
- 资助金额:
$ 45.15万 - 项目类别:
Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCT
中和抗体在 HIV-1 感染和接种疫苗的母亲中在 MTCT 中的作用
- 批准号:
9064432 - 财政年份:2016
- 资助金额:
$ 45.15万 - 项目类别:
Critical domains for HIV-1 entry through atypical coreceptor usage
通过非典型辅助受体使用进入 HIV-1 的关键领域
- 批准号:
8712360 - 财政年份:2013
- 资助金额:
$ 45.15万 - 项目类别:
Critical domains for HIV-1 entry through atypical coreceptor usage
通过非典型辅助受体使用进入 HIV-1 的关键领域
- 批准号:
8540772 - 财政年份:2013
- 资助金额:
$ 45.15万 - 项目类别:
Immunogenicity of an HIV virus-like particle vaccine
HIV病毒样颗粒疫苗的免疫原性
- 批准号:
6590286 - 财政年份:2003
- 资助金额:
$ 45.15万 - 项目类别:
Role of Virus Recombination in Multiple Drug Resisitance
病毒重组在多重耐药性中的作用
- 批准号:
6693386 - 财政年份:2003
- 资助金额:
$ 45.15万 - 项目类别:
A Universal Env Immunogen for all HIV-1 Subtypes
适用于所有 HIV-1 亚型的通用包膜免疫原
- 批准号:
6797893 - 财政年份:2003
- 资助金额:
$ 45.15万 - 项目类别:
Immunogenicity of an HIV virus-like particle vaccine
HIV病毒样颗粒疫苗的免疫原性
- 批准号:
6701755 - 财政年份:2003
- 资助金额:
$ 45.15万 - 项目类别:
Role of Virus Recombination in Multiple Drug Resisitance
病毒重组在多重耐药性中的作用
- 批准号:
6590226 - 财政年份:2003
- 资助金额:
$ 45.15万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 45.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 45.15万 - 项目类别:
Standard Grant














{{item.name}}会员




